Frontlight ResearchEarly access
Type 2 diabetes trials in Saudi Arabia
10 of 11 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Dammam, Jeddah, Riyadh
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Not yet taking people in Saudi ArabiaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Al Ahsa, Jeddah, Khobar, Riyadh, Ulaishah, Riyadh
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - Phase 3Not yet taking people in Saudi ArabiaA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Al Ahsa, Al Qaţīf, Jeddah, Jizan, Riyadh
- Age
- 18 years and over
- People
- 1,060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - No phaseNot yet taking people in Saudi ArabiaStress Coping Training for Nurses and Diabetes Control
- Where
- Ha'il
- Age
- 18 years and over
- People
- 204
- Run by
- The New Model of Care, Hail Health Cluster
See details and how to joinNCT07933159 - Phase 3Not yet taking people in Saudi ArabiaA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Al-Ahsa, Dammam, Jeddah, Khobar, Riyadh
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- Where
- Al-Ahsa, Dammam, Jeddah, Riyadh
- Age
- 18 years to 65 years
- People
- 130 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07613307 - Phase 3Taking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Riyadh
- Age
- 18 years to 65 years
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - No phaseNot yet taking people in Saudi ArabiaEffect of Prebiotics in Saudi Adults With Type 2 Diabetes
- Where
- Riyadh
- Age
- 45 years to 60 years
- People
- 100
- Run by
- Princess Nourah Bint Abdulrahman University
See details and how to joinNCT07464691 - No phaseTaking peopleLifestyle Management App for Adults With Diabetes Type
- Where
- Riyadh
- Age
- 18 years and over
- People
- 90
- Run by
- Princess Nourah Bint Abdulrahman University
See details and how to joinNCT05630508 - Phase 2/3Not yet taking people in Saudi ArabiaA Study of Apabetalone in Subjects With Long -COVID
- Where
- Al Mubarraz
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Resverlogix Corp
See details and how to joinNCT06590324